Unicycive Therapeutics
UNCY
UNCY
29 hedge funds and large institutions have $34.5M invested in Unicycive Therapeutics in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
30% less capital invested
Capital invested by funds: $49M → $34.5M (-$14.6M)
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$805K | |
| 2 | +$42.7K | |
| 3 | +$31.5K | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$28.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$28.6K |
Top Sellers
| 1 | -$1.17M | |
| 2 | -$575K | |
| 3 | -$521K | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$42.1K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$27.7K |
